Education
About Us
Working with TipRanks
Follow Us
Curevac N.V. (CVAC)
:CVAC
Cv09070101 Mrna Vaccine (Cvhnlc) 50 Μg, Cv09070101 Mrna Vaccine (Cvhnlc) 100 Μg, Cv09070101 Mrna Vaccine (Cvhnlc) 200 Μg, Cv09070101 Mrna Vaccine (Cvhnlc) 400 Μg
Squamous Nsclc
Phase I
Not Yet Recruiting
Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC)
Jul 09, 2025
―
Cv09050101 Mrna Vaccine (Cvgbm) 12 Μg, Cv09050101 Mrna Vaccine (Cvgbm) 25 Μg, Cv09050101 Mrna Vaccine (Cvgbm) 50 Μg, Cv09050101 Mrna Vaccine (Cvgbm) 100 Μg, Cv09050101 Mrna Vaccine Rde 100 Μg, Cv09050101 Mrna Vaccine (Cvgbm) 6 Μg
Glioblastoma
Phase I
Active Not Recruiting
Safety and Tolerability of CVGBM in Adults with Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
Jun 06, 2023
―
Rabipur®, Rabies Mrna Vaccine Cv7202
Rabies
Phase I
Completed
A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults
Oct 18, 2018
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Curevac N.V. (CVAC) have in its pipeline
CVAC is currently developing the following drugs: Cv09070101 Mrna Vaccine (Cvhnlc) 50 Μg, Cv09070101 Mrna Vaccine (Cvhnlc) 100 Μg, Cv09070101 Mrna Vaccine (Cvhnlc) 200 Μg, Cv09070101 Mrna Vaccine (Cvhnlc) 400 Μg, Cv09050101 Mrna Vaccine (Cvgbm) 12 Μg, Cv09050101 Mrna Vaccine (Cvgbm) 25 Μg, Cv09050101 Mrna Vaccine (Cvgbm) 50 Μg, Cv09050101 Mrna Vaccine (Cvgbm) 100 Μg, Cv09050101 Mrna Vaccine Rde 100 Μg, Cv09050101 Mrna Vaccine (Cvgbm) 6 Μg, Rabipur®, Rabies Mrna Vaccine Cv7202. These drug candidates are in various stages of clinical development as the company works toward FDA approval.